Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life

Clinical Immunology

Volumn 130, Issue 3, 2009, Pages 280-289

  Mansoor, Nazma ^a   Abel, Brian ^a   Scriba, Thomas J ^a   Hughes, Jane ^a   de Kock, Marwou ^a   Tameris, Michele ^a   Mlenjeni, Sylvia ^a   Denation, Lea ^a   Little, Francesca ^b   Gelderbloem, Sebastian ^a   Hawkridge, Anthony ^a   Boom, W Henry ^c   Kaplan, Gilla ^d   Hussey, Gregory D ^a   Hanekom, Willem A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

CD4; CD8; HIV 1; Infants; Memory

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; T LYMPHOCYTE SUBPOPULATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PHENOTYPE; T-LYMPHOCYTE SUBSETS;

EID: 59249083031     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.09.006     Document Type: Article

References (51)

1. Klenerman P., and Hill A. T cells and viral persistence: lessons from diverse infections. Nat.Immunol. 6 (2005) 873-879
2. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu.Rev.Immunol. 2 (2004) 745-763
3. Seder R.A., and Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat.Immunol. 4 (2003) 835-842
4. Marshall D.R., Turner S.J., Belz G.T., Wingo S., Andreansky S., Sangster M.Y., Riberdy J.M., Liu T., Tan M., and Doherty P.C. Measuring the diaspora for virus-specific CD8+ T cells. Proc.Natl. Acad. Sci. U. S. A. 98 (2001) 6313-6318
5. Masopust D., Vezys V., Marzo A.L., and Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291 (2001) 2413-2417
6. Reinhardt R.L., Khoruts A., Merica R., Zell T., and Jenkins M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410 (2001) 101-105
7. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., von Andrian U.H., and Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4 (2003) 225-234
8. Lloyd T.E., Yang L., Tang D.N., Bennett T., Schober W., and Lewis D.E. Regulation of CD28 costimulation in human CD8+ T cells. J. Immunol. 158 (1997) 1551-1558
9. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., Casazza J.P., Kuruppu J., Migueles S.A., Connors M., Roederer M., Douek D.C., and Koup R.A. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101 (2003) 2711-2720
10. Douek D.C. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5 (2003) 172-177
11. Douek D.C., Picker L.J., and Koup R.A. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21 (2003) 265-304
12. Hazenberg M.D., Hamann D., Schuitemaker H., and Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat. Immunol. 1 (2000) 285-289
13. Clerici M., Saresella M., Colombo F., Fossati S., Sala N., Bricalli D., Villa M.L., Ferrante P., Dally L., and Vigano A. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 96 (2000) 3866-3871
14. McCloskey T.W., Kohn N., Lesser M., Bakshi S., and Pahwa S. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets. Cytometry 46 (2001) 157-165
15. Shearer W.T., Easley K.A., Goldfarb J., Rosenblatt H.M., Jenson H.B., Kovacs A., and McIntosh K. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J. Allergy Clin. Immunol. 106 (2000) 559-566
16. Kharbanda M., McCloskey T.W., Pahwa R., Sun M., and Pahwa S. Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children. Clin. Diagn. Lab. Immunol. 10 (2003) 53-58
17. Deeks S.G., Kitchen C.M., Liu L., Guo H., Gascon R., Narvaez A.B., Hunt P., Martin J.N., Kahn J.O., Levy J., McGrath M.S., and Hecht F.M. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104 (2004) 942-947
18. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., Hamann D., Prins M., and Miedema F. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids 17 (2003) 1881-1888
19. Aandahl E.M., Quigley M.F., Moretto W.J., Moll M., Gonzalez V.D., Sonnerborg A., Lindback S., Hecht F.M., Deeks S.G., Rosenberg M.G., Nixon D.F., and Sandberg J.K. Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood 104 (2004) 3672-3678
20. Rabin R.L., Roederer M., Maldonado Y., Petru A., Herzenberg L.A., and Herzenberg L.A. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J Clin. Invest. 95 (1995) 2054-2060
21. Resino S., Correa R., Bellon J.M., and Munoz-Fernandez M.A. Preserved immune system in long-term asymptomatic vertically HIV-1 infected children. Clin. Exp. Immunol. 132 (2003) 105-112
22. Jordan K.A., Furlan S.N., Gonzalez V.D., Karlsson A.C., Quigley M.F., Deeks S.G., Rosenberg M.G., Nixon D.F., and Sandberg J.K. CD8 T cell effector maturation in HIV-1-infected children. Virology 347 (2006) 117-126
23. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G.P., Fleury S., Lipp M., Forster R., Rowland-Jones S., Sekaly R.P., McMichael A.J., and Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 (2001) 106-111
24. Harari A., Vallelian F., and Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34 (2004) 3525-3533
25. Kourtis A.P., Ibegbu C., Nahmias A.J., Lee F.K., Clark W.S., Sawyer M.K., and Nesheim S. Early progression of disease in HIV-infected infants with thymus dysfunction. N. Engl. J. Med. 335 (1996) 1431-1436
26. Newell M.L., Coovadia H., Cortina-Borja M., Rollins N., Gaillard P., and Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364 (2004) 1236-1243
27. Newell M.L., Brahmbhatt H., and Ghys P.D. Child mortality and HIV infection in Africa: a review. Aids 18 Suppl. 2 (2004) S27-S34
28. Rich K.C., Siegel J.N., Jennings C., Rydman R.J., and Landay A.L. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin. Diagn. Lab. Immunol. 4 (1997) 358-361
29. Kuhn L., Meddows-Taylor S., Gray G., and Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin. Infect. Dis. 34 (2002) 267-276
30. Ssewanyana I., Elrefaei M., Dorsey G., Ruel T., Jones N.G., Gasasira A., Kamya M., Nakiwala J., Achan J., Charlebois E., Havlir D., and Cao H. Profile of T cell immune responses in HIV-infected children from Uganda. J. Infect. Dis. 196 (2007) 1667-1670
31. Brown H., and Prescott R. Applied Mixed Models in Medicine (2004) Wiley
32. Brugnoni D., Prati E., Malacarne F., Gorla R., Airo P., and Cattaneo R. The primary response to HIV infection is characterized by an expansion of activated CD8+ CD28- cells. Aids 10 (1996) 104-106
33. Gruters R.A., Terpstra F.G., De Goede R.E., Mulder J.W., De Wolf F., Schellekens P.T., Van Lier R.A., Tersmette M., and Miedema F. Immunological and virological markers in individuals progressing from seroconversion to AIDS. Aids 5 (1991) 837-844
34. Papagno L., Spina C.A., Marchant A., Salio M., Rufer N., Little S., Dong T., Chesney G., Waters A., Easterbrook P., Dunbar P.R., Shepherd D., Cerundolo V., Emery V., Griffiths P., Conlon C., McMichael A.J., Richman D.D., Rowland-Jones S.L., and Appay V. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2 (2004) E20
35. Roederer M., Dubs J.G., Anderson M.T., Raju P.A., Herzenberg L.A., and Herzenberg L.A. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95 (1995) 2061-2066
36. Gallagher K., Gorre M., Harawa N., Dillon M., Wafer D., Stiehm E.R., Bryson Y., Song D., Dickover R., and Plaeger S. Timing of lymphocyte activation in neonates infected with human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 4 (1997) 742-747
37. Meyers A., Shah A., Cleveland R.H., Cranley W.R., Wood B., Sunkle S., Husak S., and Cooper E.R. Thymic size on chest radiograph and rapid disease progression in human immunodeficiency virus 1-infected children. Pediatr. Infect. Dis. J. 20 (2001) 1112-1118
38. Nahmias A.J., Clark W.S., Kourtis A.P., Lee F.K., Cotsonis G., Ibegbu C., Thea D., Palumbo P., Vink P., Simonds R.J., and Nesheim S.R. Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group. J. Infect. Dis. 178 (1998) 680-685
39. Harari A., Petitpierre S., Vallelian F., and Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103 (2004) 966-972
40. Buseyne F., Burgard M., Teglas J.P., Bui E., Rouzioux C., Mayaux M.J., Blanche S., and Riviere Y. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. AIDS Res. Hum. Retroviruses 14 (1998) 1435-1444
41. Luzuriaga K., Holmes D., Hereema A., Wong J., Panicali D.L., and Sullivan J.L. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154 (1995) 433-443
42. Thobakgale C.F., Ramduth D., Reddy S., Mkhwanazi N., de Pierres C., Moodley E., Mphatswe W., Blanckenberg N., Cengimbo A., Prendergast A., Tudor-Williams G., Dong K., Jeena P., Kindra G., Bobat R., Coovadia H., Kiepiela P., Walker B.D., and Goulder P.J. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J. Virol. 81 (2007) 12775-12784
43. Lohman B.L., Slyker J.A., Richardson B.A., Farquhar C., Mabuka J.M., Crudder C., Dong T., Obimbo E., Mbori-Ngacha D., Overbaugh J., Rowland-Jones S., and John-Stewart G. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J. Virol. 79 (2005) 8121-8130
44. Riviere Y., and Buseyne F. Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV. Vaccine 16 (1998) 1420-1422
45. Palmer B.E., Blyveis N., Fontenot A.P., and Wilson C.C. Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J. Immunol. 175 (2005) 8415-8423
46. Choremi-Papadopoulou H., Viglis V., Gargalianos P., Kordossis T., Iniotaki-Theodoraki A., and Kosmidis J. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7 (1994) 245-253
47. Haffar O.K., Smithgall M.D., Wong J.G., Bradshaw J., and Linsley P.S. Human immunodeficiency virus type 1 infection of CD4+ T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production. Clin. Immunol. Immunopathol. 77 (1995) 262-270
48. Swigut T., Shohdy N., and Skowronski J. Mechanism for down-regulation of CD28 by Nef. Embo J. 20 (2001) 1593-1604
49. Borthwick N.J., Bofill M., Gombert W.M., Akbar A.N., Medina E., Sagawa K., Lipman M.C., Johnson M.A., and Janossy G. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28-T cells. Aids 8 (1994) 431-441
50. Vingerhoets J.H., Vanham G.L., Kestens L.L., Penne G.G., Colebunders R.L., Vandenbruaene M.J., Goeman J., Gigase P.L., De Boer M., and Ceuppens J.L. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Clin. Exp. Immunol. 100 (1995) 425-433
51. Rabie H., Violari A., Madhi S., Gibb D.M., Steyn J., van Niekerk R., Josipovic D., Innes S., and Cotton M.F. Complications of BCG Vaccination in HIV-infected and -uninfected Children: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study (2008), CROI, Boston, USA